[ad_1]
The head of a top Russian research centre told President Vladimir Putin on Tuesday that his lab was ready to start human trials of experimental coronavirus vaccines in June.
Rinat Maksyutov, head of the Vektor State Virology and Biotechnology Centre, said his facility proposed first-phase clinical trials of three vaccines from June 29, on 180 volunteers.
Maksyutov was speaking during a video-link meeting between Putin and the heads of top research centres.
“Groups of volunteers have already been formed,” he told Putin, adding that a lot of people wanted to take part in the trials.
“We have already received more than 300 applications.”
Maksyutov said scientists at the top-secret lab complex located in Koltsovo outside the Siberian city of Novosibirsk had developed several prototype vaccines.
Tests were currently underway on mice, rabbits and other animals to determine the most promising by April 30, he said.
Vektor planned pre-clinical studies by June 22 before launching the testing in humans, Maksyutov added.
But the first human trials could begin in May “if the health ministry allows it”.
Vektor has vaccine platform technologies that have already been tested in humans for other infections and could be used for the coronavirus, he added.
The Vektor laboratory complex conducted secret biological weapons research in the Soviet era and stockpiles viruses ranging from Ebola to smallpox.
Russia on Tuesday reported 7,497 coronavirus cases and 58 fatalities but the real number of infections is believed to be much higher.
Follow the latest news on the coronavirus (COVID-19) outbreak
© 2020 AFP
Citation:
Russia ready to start testing coronavirus vaccines on humans in June (2020, April 7)
retrieved 7 April 2020
from https://medicalxpress.com/news/2020-04-russia-ready-coronavirus-vaccines-humans.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.
[ad_2]
Source link
- COVID case rates hit new high for England, study finds - April 7, 2022
- Govt’s focus on affordable healthcare ensured significant savings for poor, middle class: PM Modi - April 7, 2022
- SRL Diagnostics and Skye Air Mobility collaborate to transport pathology samples using drone logistics - April 6, 2022
- Healthineers sets up new production line of CT scanners in Bengaluru under PLI scheme - April 6, 2022
- Lupin inks licensing pact with Alvion to market drugs in Southeast Asia - April 6, 2022
- Yoga Mahotsav: Ayush Ministry to organise event to demonstrate common yoga on World Health Day - April 6, 2022
- LordsMed forays into the medtech space with launch of health ATMs ‘Lords Sehat’ - April 5, 2022
- ‘Friendly viruses’ can be the next big thing in the history of medical research and more - April 5, 2022
- No setback to Bharat Biotech even as WHO suspends Covaxin UN supply: Sources - April 4, 2022
- Govt panel recommends Serum’s Covovax dose for kids aged 12 and above - April 4, 2022
